MDXH
MDxHealth·NASDAQ
--
--(--)
--
--(--)
3.58 / 10
Netural
Fund flow evaluation is robust at 7.16/10, with positive Small and Medium trends despite overall block outflows. Analyst sentiment is overwhelmingly bullish (100% Strong Buy from one report), yet historical win rates are low (0.0%), and the current price trend is falling (-8.85%). This divergence between positive money flow and weak analyst reliability adds uncertainty to near-term momentum.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-23
InstitutionBTIG
Times predicted2
Historical Win Rate0.0%
What is the analyst consensus for MDXH?
- MDXH holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.58/10 (Netural).
